Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.150
+0.100 (4.88%)
At close: Oct 27, 2025, 4:00 PM EDT
2.100
-0.050 (-2.33%)
Pre-market: Oct 28, 2025, 4:27 AM EDT
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $50.1 million as of October 28, 2025. Its market cap has decreased by -52.32% in one year.
Market Cap
50.10M
Enterprise Value
32.97M
1-Year Change
-52.32%
Ranking
Category
Stock Price
$2.15
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $50.10M, a decrease of -19.85%. That is a compound annual growth rate of -3.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 47.77M | -31.17% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |